Earlier this week, the FDA granted marketing approval for IDx-DR, the first
artificial intelligence medical device to detect more than a mild level of diabetic retinopathy in adults with diabetes, as reported by Ocular Surgery News. In March, the IDx inventors were awarded the first-of-its-kind U.S. patent for ...